Practical medical manual of biomedicines used in the treatment of autoimmune diseases and in certain hemopathies.This is an edition intended for medical and paramedical personnel.Characteristics: - Content available offline. -Very simple, practical and free application. -The main molecules and active ingredients. -Ability to quickly search in the application (substance name or trade name) -The necessary assessment before starting a biotherapy. -Presentations, forms, premedication, dosage and rate of taking biotherapies. -Availability, price and reimbursement (Morocco). - Monitoring methods: Tolerance, efficacy and time to therapeutic response. -Practical situations: what to do in case of trauma, burn, dental care, pregnancy or breastfeeding. -Bibliographical references for each molecule (internet connection required).List of molecules included:- Anti-TNF: INFLIXIMAB, ETANERCEPT, ADALIMUMAB, GOLIMUMAB, CERTOLIZUMAB PEGOL…- Anti-CD28: ABATACEPT- Anti-IL1: ANAKINRA, CANAKINUMAB…- Anti-IL6: TOCILIZUMAB, SARILUMAB, SILTUXIMAB ...- Anti- (IL12 and IL23): USTEKINUMAB- Anti-IL17: SECUKINUMAB, BRODALUMAB, IXEKIZUMAB…- Anti-CD20: RITUXIMAB- Anti-RANK ligand: DENOSUMAB- Anti-BLyS: BELIMUMAB- Anti-JAK: TOFACITINIB, BARICITINB, RUXOLITINIB, UPADACITINIB, FILGOTINIB…Important Notes: **** By installing this application, you automatically agree to the terms and rules of use: 1 - This is a free application, a practical guide to the use of biomedicines for staff and students in the medical and paramedical field of the specialties concerned. 2 - Disclaimer:A - The content of the application comes from different sources (see References). The author accepts no responsibility for any unintentional error that may arise from a reference, a typo or a misunderstanding.B - The author does not take any responsibility if damage has been caused to your device due to the application.C - The author retains the right - at any time - to update, modify or delete the content of the application. 3 - Any reproduction must be made only after the consent of the author. * Information *: ** The addition of other sections and molecules is planned in the next updates ** The indications, dosages, rate of administration and the therapeutic response category are currently available mainly for rheumatology. The addition of other information will be done regularly. ** Do not hesitate to contact us with the slightest concern or suggestion.Written content and application engine developed by Doctor SOUHIL ERRAFIA (ERRAFIOS), doctor specializing in rheumatology.
Biotherapy Plus (french)
